Govt gives nod to BioE3 policy, Vigyan Dhara scheme to foster R&D

Along with prioritising regenerative bioeconomy models of green growth, this policy will facilitate the expansion of India's skilled workforce and provide a surge in job creation

PM Modi chairs first meeting of his new Cabinet
The Union Cabinet also approved the continuation of three umbrella schemes of the Department of Science and Technology. | PTI Photo
Press Trust of India New Delhi
3 min read Last Updated : Aug 24 2024 | 8:30 PM IST

The Union Cabinet on Saturday approved the 'BioE3' (Biotechnology for Economy, Environment and Employment) policy for fostering high-performance biomanufacturing of the Department of Biotechnology.

According to Information and Broadcasting Minister Ashwini Vaishnaw, the BioE3 policy seeks to include innovation-driven support for research and development and entrepreneurship across thematic sectors.

This will accelerate technology development and commercialisation by establishing biomanufacturing and bio-AI hubs and biofoundry, he said.

Along with prioritising regenerative bioeconomy models of green growth, this policy will facilitate the expansion of India's skilled workforce and provide a surge in job creation.


 


An official statement said, the policy will further strengthen the government's initiatives such as a Net Zero' carbon economy and Lifestyle for Environment' and will steer India on the path of accelerated Green Growth' by promoting a Circular Bioeconomy'.

 

"The BioE3 Policy will foster and advance a future that is more sustainable, innovative, and responsive to global challenges and lays down the Bio-vision for Viksit Bharat," the statement said.

Our present era is an opportune time to invest in the industrialisation of biology to promote sustainable and circular practices to address some of the critical societal issues such as climate change mitigation, food security and human health, it said.

It is important to build a resilient biomanufacturing ecosystem in our nation to accelerate cutting-edge innovations for developing bio-based products.

High-performance biomanufacturing is the ability to produce products from medicine to materials, address farming and food challenges, and promote manufacturing of bio-based products through the integration of advanced biotechnological processes, the statement said.

To address the national priorities, the BioE3 Policy would broadly focus on the following strategic/thematic sectors: high-value bio-based chemicals, biopolymers and enzymes; smart proteins and functional foods; precision biotherapeutics; climate resilient agriculture; carbon capture and its utilisation; marine and space research, it said.

The Union Cabinet also approved the continuation of three umbrella schemes of the Department of Science and Technology, merged into a unified central sector scheme called 'Vigyan Dhara'.



The proposed outlay for Vigyan Dhara is Rs 10,579 crore during the 15th Finance Commission period from 2021-22 to 2025-26, Information and Broadcasting Minister Ashwini Vaishnaw told reporters.

The scheme has three broad components -- science and technology institutional and human capacity building; research and development; and innovation, technology development and deployment.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CabinetBiotechnologyResearch and development

First Published: Aug 24 2024 | 8:28 PM IST

Next Story